Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 20, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Licenses Intellectual Property Related to Parkinson's Disease From Universite Laval

NOVATO, Calif., June 20, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that the Company has acquired exclusive rights to intellectual...
June 18, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Completes Enrollment in Phase 2/3 Clinical Trial of RP103 for the Potential Treatment of Huntington's Disease

NOVATO, Calif., June 18, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that enrollment is complete in its Phase 2/3 clinical trial of...
June 13, 2012 16:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Announces FDA Acceptance of New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis

NOVATO, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that the U.S. Food and Drug Administration ("FDA") has accepted...
June 12, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the 2012 Wells Fargo Securities Healthcare Conference

NOVATO, Calif., June 12, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Christopher M. Starr, Ph.D., Chief Executive Officer of...
May 29, 2012 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Licenses Intellectual Property Related to Malaria From McGill University

NOVATO, Calif., May 29, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced that the Company has acquired exclusive rights to intellectual...
May 14, 2012 09:19 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Added to NASDAQ Biotechnology Index

NOVATO, Calif., May 14, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced that NASDAQ is adding Raptor to the NASDAQ Biotechnology Index...
May 03, 2012 13:11 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Announces Publication of Phase 3 Results in the Clinical Journal of the American Society of Nephrology

NOVATO, Calif., May 3, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced the online publication of an article titled, "A Randomized Controlled...
May 03, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences

NOVATO, Calif., May 3, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Christopher M. Starr, Ph.D., Chief Executive Officer of...
May 01, 2012 06:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Announces At-the-Market Common Stock Sales Program

NOVATO, Calif., May 1, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that it has entered into an "At-the-Market" ("ATM") Sales...
April 12, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at Cystinosis Research Foundation Day of Hope Family Conference

NOVATO, Calif., April 12, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that Ted Daley, President, will present an update on its...